Smart insulin pump could transform hospital diabetes care

NCT ID NCT06418880

Completed Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an automated insulin delivery system (the Omnipod 5) in 130 hospitalized adults with type 1 or type 2 diabetes. Patients were randomly assigned to use the automated system or standard insulin injections plus a continuous glucose monitor. The goal was to see if the automated system kept blood sugar in a healthy range more safely and effectively during their hospital stay.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omnipod 5 automated insulin delivery system
What this could lead to: If it works, this could offer a safer, more effective way to manage blood sugar in hospitalized diabetes patients, reducing complications.
What could go wrong: This is a completed Phase 3 trial with 130 participants, but results may not apply to all hospital settings or patients. The device may have technical issues or not outperform standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES TYPE 2 DIABETES

Contacts and locations

Show contact details

Locations

Grady Health System (non-CRN)

Atlanta, Georgia, 30322, United States
Stanford University School of Medicine

Stanford, California, 94305, United States
University of Virginia School of Medicine

Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.